Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.15
-0.03 (-0.58%)
Jan 28, 2026, 11:10 AM EST - Market open
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $658.5 million as of January 28, 2026. Its market cap has decreased by -25.15% in one year.
Market Cap
658.50M
Enterprise Value
425.43M
1-Year Change
-25.15%
Ranking
Category
Stock Price
$5.15
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $658.50M, a decrease of -70.87%. That is a compound annual growth rate of -23.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 664.90M | 2.97% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 827.60M |
| Pacific Biosciences of California | 778.92M |
| SI-BONE | 728.97M |
| Beta Bionics | 702.63M |
| Tactile Systems Technology | 647.29M |
| Avanos Medical | 607.62M |
| Standard BioTools | 596.08M |
| Varex Imaging | 580.58M |